Cannabigerol, or CBG, was discovered in 1964 by Yehiel Gaoni and Raphael Mechoulam in Israel and has shown a wide range of medicinal efficacy. This includes research indicating that it may be effective in the treatment of bladder dysfunction, cancer in general, colon cancer specifically, glaucoma, Huntington disease, immune dysfunction, multiple sclerosis, and inflammatory bowel disease.
Cannabigerol (CBG)
Updated: Jul 13, 2022
Want to read more?
Subscribe to higherlearninglv.co to keep reading this exclusive post.